Show simple item record

dc.contributor.authorMalick, Huzaifa
dc.date.accessioned2023-06-21T12:53:56Z
dc.date.available2023-06-21T12:53:56Z
dc.identifier.citationMalick, H., Wilde, C., & Stead, R. E. (2023). Combined aqueous misdirection and persistent choroidal effusions following implantation of a Preserflo MicroShunt. International journal of ophthalmology, 16(4), 652–655. https://doi.org/10.18240/ijo.2023.04.21en_US
dc.identifier.other10.18240/ijo.2023.04.21
dc.identifier.urihttp://hdl.handle.net/20.500.12904/17227
dc.description.abstractAim: To describe a case of aqueous misdirection complicated by subsequent persistent choroidal effusions following implantation of a Preserflo MicroShunt (PMS) device to treat advanced closed angle glaucoma. Methods: A 67-year-old caucasian female with advanced primary angle-closure glaucoma on four medications with an intraocular pressure (IOP) of 26 mm Hg was listed for a PMS insertion with mitomycin C (MMC). Results: Past ocular history was significant for pseudophakia and previous yttrium aluminum garnet (YAG) peripheral iridotomy. Surgery was uneventful but on the first postoperative day, she developed aqueous misdirection complicated by subsequent development of persistent uveal effusions. Conventional treatment strategies including atropine drops, YAG hyaloidotomy and choroidal effusion drainage proved ineffective. A combination of oral steroids and pars plana vitrectomy (PPV) along with an irido-zonulo-hyloidectomy (IZH) proved efficacious. Conclusion: To the best of the author's knowledge, this is the first published case of aqueous misdirection complicated with the presence of significant, unresolving choroidal effusions, highlighting the possibility and sequelae of comorbid pathology in nanophthalmic eyes.
dc.description.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089895/en_US
dc.language.isoenen_US
dc.subjectAqueousen_US
dc.subjectChoroidalen_US
dc.subjectCombineden_US
dc.subjectEffusionsen_US
dc.subjectMisdirectionsen_US
dc.subjectPersistenten_US
dc.titleCombined aqueous misdirection and persistent choroidal effusions following implantation of a Preserflo MicroShunten_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.versionofrecordhttps://doi.org/10.18240/ijo.2023.04.21en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2023-04-18
html.description.abstractAim: To describe a case of aqueous misdirection complicated by subsequent persistent choroidal effusions following implantation of a Preserflo MicroShunt (PMS) device to treat advanced closed angle glaucoma. Methods: A 67-year-old caucasian female with advanced primary angle-closure glaucoma on four medications with an intraocular pressure (IOP) of 26 mm Hg was listed for a PMS insertion with mitomycin C (MMC). Results: Past ocular history was significant for pseudophakia and previous yttrium aluminum garnet (YAG) peripheral iridotomy. Surgery was uneventful but on the first postoperative day, she developed aqueous misdirection complicated by subsequent development of persistent uveal effusions. Conventional treatment strategies including atropine drops, YAG hyaloidotomy and choroidal effusion drainage proved ineffective. A combination of oral steroids and pars plana vitrectomy (PPV) along with an irido-zonulo-hyloidectomy (IZH) proved efficacious. Conclusion: To the best of the author's knowledge, this is the first published case of aqueous misdirection complicated with the presence of significant, unresolving choroidal effusions, highlighting the possibility and sequelae of comorbid pathology in nanophthalmic eyes.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record